PKLR and familial pancreatic carcinoma: Therefore, such a strategy of cutting off the glycolytic ATP supply to the PMCA in pancreatic cancer cells would be predicted to be relatively more effective in cancer cells while leaving non-cancerous cells that rely on catalytically active pyruvate kinase (PKL or PKM1) or mitochondria as the major ATP supply, relatively intact.